{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:54:45Z","timestamp":1790949285930,"version":"4.1.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R01AT011162"],"award-info":[{"award-number":["R01AT011162"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-03031-7","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T23:38:01Z","timestamp":1783553881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Calcium signaling in human and mouse microglia exhibit differential susceptibility to phytocannabinoids"],"prefix":"10.1186","volume":"24","author":[{"given":"Ivana","family":"Pilchova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Fleig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold","family":"Penner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"4","key":"3031_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz JD, Seeher KM, Schiess N, Nichols E, Cao B, Servili C, et al. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(4):344\u201381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3.","journal-title":"Lancet Neurol"},{"issue":"3","key":"3031_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ceca.2012.12.003","volume":"53","author":"B Brawek","year":"2013","unstructured":"Brawek B, Garaschuk O. Microglial calcium signaling in the adult, aged and diseased brain. Cell Calcium. 2013;53(3):159\u201369. https:\/\/doi.org\/10.1016\/j.ceca.2012.12.003.","journal-title":"Cell Calcium"},{"issue":"4","key":"3031_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/neuroglia5040027","volume":"5","author":"AR Hasan","year":"2024","unstructured":"Hasan AR, Tasnim F, Aktaruzzaman Md, Islam MT, Rayhan R, Brishti A, et al. The Alteration of Microglial Calcium Homeostasis in Central Nervous System Disorders: A Comprehensive Review. Neuroglia. 2024;5(4):410\u201344. https:\/\/doi.org\/10.3390\/neuroglia5040027.","journal-title":"Neuroglia"},{"issue":"4","key":"3031_CR4","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/glia.22775","volume":"63","author":"M Michaelis","year":"2015","unstructured":"Michaelis M, Nieswandt B, Stegner D, Eilers J, Kraft R. STIM1, STIM2, and Orai1 regulate store-operated calcium entry and purinergic activation of microglia: STIM1, STIM2 and Orai1 in Microglia. Glia. 2015;63(4):652\u201363. https:\/\/doi.org\/10.1002\/glia.22775.","journal-title":"Glia"},{"issue":"1","key":"3031_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12264-013-1343-x","volume":"30","author":"A Verkhratsky","year":"2014","unstructured":"Verkhratsky A, Parpura V. Store-operated calcium entry in neuroglia. Neurosci Bull. 2014;30(1):125\u201333. https:\/\/doi.org\/10.1007\/s12264-013-1343-x.","journal-title":"Neurosci Bull"},{"issue":"1","key":"3031_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cellsig.2014.11.003","volume":"27","author":"DK Heo","year":"2015","unstructured":"Heo DK, Lim HM, Nam JH, Lee MG, Kim JY. Regulation of phagocytosis and cytokine secretion by store-operated calcium entry in primary isolated murine microglia. Cell Signal. 2015;27(1):177\u201386. https:\/\/doi.org\/10.1016\/j.cellsig.2014.11.003.","journal-title":"Cell Signal"},{"key":"3031_CR7","doi-asserted-by":"publisher","first-page":"106273","DOI":"10.1016\/j.nbd.2023.106273","volume":"186","author":"C Chen","year":"2023","unstructured":"Chen C, Zhu T, Gong L, Hu Z, Wei H, Fan J, et al. Trpm2 deficiency in microglia attenuates neuroinflammation during epileptogenesis by upregulating autophagy via the AMPK\/mTOR pathway. Neurobiol Dis. 2023;186:106273. https:\/\/doi.org\/10.1016\/j.nbd.2023.106273.","journal-title":"Neurobiol Dis"},{"key":"3031_CR8","doi-asserted-by":"publisher","first-page":"742065","DOI":"10.3389\/fnins.2021.742065","volume":"15","author":"L Muzio","year":"2021","unstructured":"Muzio L, Viotti A, Martino G. Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy. Front Neurosci. 2021;15:742065. https:\/\/doi.org\/10.3389\/fnins.2021.742065.","journal-title":"Front Neurosci"},{"issue":"12","key":"3031_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2174\/1567205018666210119143817","volume":"17","author":"JG McLarnon","year":"2020","unstructured":"McLarnon JG. Microglial Store-operated Calcium Signaling in Health and in Alzheimer\u2019s Disease. Curr Alzheimer Res. 2020;17(12):1057\u201364. https:\/\/doi.org\/10.2174\/1567205018666210119143817.","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"3031_CR10","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1007\/s12035-021-02717-y","volume":"59","author":"Z Sun","year":"2022","unstructured":"Sun Z, Li X, Yang L, Dong X, Han Y, Li Y, et al. SOCE-mediated NFAT1\u2013NOX2\u2013NLRP1 inflammasome involves in lipopolysaccharide-induced neuronal damage and A\u03b2 generation. Mol Neurobiol. 2022;59(5):3183\u2013205. https:\/\/doi.org\/10.1007\/s12035-021-02717-y.","journal-title":"Mol Neurobiol"},{"key":"3031_CR11","doi-asserted-by":"crossref","unstructured":"Tsujikawa S, DeMeulenaere KE, Centeno MV, Ghazisaeidi S, Martin ME, Tapies MR et al. Regulation of neuropathic pain by microglial Orai1 channels. Sci. Adv. 2023;9:eade7002. https:\/\/www.science.org\/doi\/epdf\/10.1126\/sciadv.ade7002.\u00a0","DOI":"10.1126\/sciadv.ade7002"},{"key":"3031_CR12","doi-asserted-by":"publisher","first-page":"e73021","DOI":"10.7554\/eLife.73021","volume":"11","author":"A Jairaman","year":"2022","unstructured":"Jairaman A, McQuade A, Granzotto A, Kang YJ, Chadarevian JP, Gandhi S et al. M <>PrakriyaAldrichTrebak RW M editors. 2022 TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microglia. eLife 11 e73021 https:\/\/doi.org\/10.7554\/eLife.73021.","journal-title":"eLife"},{"issue":"9","key":"3031_CR13","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/plants14091372","volume":"14","author":"R Boucher","year":"2025","unstructured":"Boucher R, Germain H, Desgagn\u00e9-Penix I. Exploring the Lesser-Known Bioactive Natural Products of Plant Species of the Genus Cannabis L.: Alkaloids, Phenolic Compounds, and Their Therapeutic Potential. Plants. 2025;14(9):1372. https:\/\/doi.org\/10.3390\/plants14091372.","journal-title":"Plants"},{"issue":"5","key":"3031_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","volume":"78","author":"MA ElSohly","year":"2005","unstructured":"ElSohly MA, Slade D. Chemical constituents of marijuana: The complex mixture of natural cannabinoids. Life Sci. 2005;78(5):539\u201348. https:\/\/doi.org\/10.1016\/j.lfs.2005.09.011.","journal-title":"Life Sci"},{"key":"3031_CR15","doi-asserted-by":"publisher","first-page":"1200269","DOI":"10.3389\/fphar.2023.1200269","volume":"14","author":"E Fordjour","year":"2023","unstructured":"Fordjour E, Manful CF, Sey AA, Javed R, Pham TH, Thomas R, et al. Cannabis: a multifaceted plant with endless potentials. Front Pharmacol. 2023;14:1200269. https:\/\/doi.org\/10.3389\/fphar.2023.1200269.","journal-title":"Front Pharmacol"},{"issue":"2","key":"3031_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/molecules29020410","volume":"29","author":"AK Al-Khazaleh","year":"2024","unstructured":"Al-Khazaleh AK, Zhou X, Bhuyan DJ, M\u00fcnch GW, Al-Dalabeeh EA, Jaye K, et al. The Neurotherapeutic Arsenal in Cannabis sativa: Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects. Molecules. 2024;29(2):410. https:\/\/doi.org\/10.3390\/molecules29020410.","journal-title":"Molecules"},{"issue":"5","key":"3031_CR17","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/ptr.7458","volume":"36","author":"V Borgonetti","year":"2022","unstructured":"Borgonetti V, Benatti C, Governa P, Isoldi G, Pellati F, Alboni S, et al. Non-psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors\u2010, endocannabinoids\u2010, and NF\u2010\u03baB \u2010mediated signaling. Phytother Res. 2022;36(5):2246\u201363. https:\/\/doi.org\/10.1002\/ptr.7458.","journal-title":"Phytother Res"},{"issue":"8","key":"3031_CR18","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.3390\/ijms25084204","volume":"25","author":"NM Blebea","year":"2024","unstructured":"Blebea NM, Pricopie AI, Vlad RA, Hancu G, Phytocannabinoids. Exploring Pharmacological Profiles and Their Impact on Therapeutical Use. IJMS. 2024;25(8):4204. https:\/\/doi.org\/10.3390\/ijms25084204.","journal-title":"IJMS"},{"key":"3031_CR19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3389\/fphar.2018.00632","volume":"9","author":"G Navarro","year":"2018","unstructured":"Navarro G, Varani K, Reyes-Resina I, De S\u00e1nchez V, Rivas-Santisteban R, S\u00e1nchez-Carnerero Callado C, et al. Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1\u2013CB2 Heteroreceptor Complexes. Front Pharmacol. 2018;9:632. https:\/\/doi.org\/10.3389\/fphar.2018.00632.","journal-title":"Front Pharmacol"},{"issue":"20","key":"3031_CR20","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1073\/pnas.0511232103","volume":"103","author":"EJ Carrier","year":"2006","unstructured":"Carrier EJ, Auchampach JA, Hillard CJ. Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci USA. 2006;103(20):7895\u2013900. https:\/\/doi.org\/10.1073\/pnas.0511232103.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"3031_CR21","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3390\/antiox11102049","volume":"11","author":"A Tadijan","year":"2022","unstructured":"Tadijan A, Vla\u0161i\u0107 I, Vlaini\u0107 J, \u0110iki\u0107 D, Or\u0161oli\u0107 N, Jazvin\u0161\u0107ak Jembrek M. Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions. Antioxidants. 2022;11(10):2049. https:\/\/doi.org\/10.3390\/antiox11102049.","journal-title":"Antioxidants"},{"key":"3031_CR22","doi-asserted-by":"publisher","first-page":"111653","DOI":"10.1016\/j.cellsig.2025.111653","volume":"128","author":"S Liu","year":"2025","unstructured":"Liu S, Ma Z. The role of cannabinoid-mediated signaling pathways and mechanisms in brain disorders. Cell Signal. 2025;128:111653. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111653.","journal-title":"Cell Signal"},{"issue":"7","key":"3031_CR23","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","volume":"163","author":"L De Petrocellis","year":"2011","unstructured":"De Petrocellis L, Ligresti A, Moriello AS, Allar\u00e0 M, Bisogno T, Petrosino S, et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011;163(7):1479\u201394. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01166.x.","journal-title":"Br J Pharmacol"},{"key":"3031_CR24","doi-asserted-by":"publisher","first-page":"154771","DOI":"10.1016\/j.phymed.2023.154771","volume":"114","author":"S Khosropoor","year":"2023","unstructured":"Khosropoor S, Alavi MS, Etemad L, Roohbakhsh A. Cannabidiol goes nuclear: The role of PPAR\u03b3. Phytomedicine. 2023;114:154771. https:\/\/doi.org\/10.1016\/j.phymed.2023.154771.","journal-title":"Phytomedicine"},{"issue":"7","key":"3031_CR25","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","volume":"152","author":"E Ryberg","year":"2007","unstructured":"Ryberg E, Larsson N, Sj\u00f6gren S, Hjorth S, Hermansson N, Leonova J, et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 2007;152(7):1092\u2013101. https:\/\/doi.org\/10.1038\/sj.bjp.0707460.","journal-title":"Br J Pharmacol"},{"issue":"8","key":"3031_CR26","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","volume":"30","author":"EB Russo","year":"2005","unstructured":"Russo EB, Burnett A, Hall B, Parker KK. Agonistic Properties of Cannabidiol at 5-HT1a Receptors. Neurochem Res. 2005;30(8):1037\u201343. https:\/\/doi.org\/10.1007\/s11064-005-6978-1.","journal-title":"Neurochem Res"},{"issue":"4","key":"3031_CR27","doi-asserted-by":"publisher","first-page":"zqac033","DOI":"10.1093\/function\/zqac033","volume":"3","author":"M Faouzi","year":"2022","unstructured":"Faouzi M, Wakano C, Monteilh-Zoller MK, Neupane RP, Starkus JG, Neupane JB, et al. Acidic Cannabinoids Suppress Proinflammatory Cytokine Release by Blocking Store-operated Calcium Entry. Function. 2022;3(4):zqac033. https:\/\/doi.org\/10.1093\/function\/zqac033.","journal-title":"Function"},{"key":"3031_CR28","unstructured":"ClinicalTrials.gov search. cannabis, inflammation. Bethesda, MD: National Library of Medicine; 2025. Available from: https:\/\/clinicaltrials.gov.Cited 2025 May 29."},{"issue":"1","key":"3031_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/can.2017.0028","volume":"2","author":"NR Ryz","year":"2017","unstructured":"Ryz NR, Remillard DJ, Russo EB. Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain. Cannabis Cannabinoid Res. 2017;2(1):210\u20136. https:\/\/doi.org\/10.1089\/can.2017.0028.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"14","key":"3031_CR30","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3390\/cells12141811","volume":"12","author":"RS Mboumba Bouassa","year":"2023","unstructured":"Mboumba Bouassa RS, Comeau E, Alexandrova Y, Pagliuzza A, Yero A, Samarani S, et al. Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial. Cells. 2023;12(14):1811. https:\/\/doi.org\/10.3390\/cells12141811.","journal-title":"Cells"},{"issue":"7","key":"3031_CR31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jhsa.2022.03.002","volume":"47","author":"JT Heineman","year":"2022","unstructured":"Heineman JT, Forster GL, Stephens KL, Cottler PS, Timko MP, DeGeorge J, Brent R. A Randomized Controlled Trial of Topical Cannabidiol for the Treatment of Thumb Basal Joint Arthritis. J hand Surg (American ed). 2022;47(7):611. https:\/\/doi.org\/10.1016\/j.jhsa.2022.03.002.","journal-title":"J hand Surg (American ed)"},{"issue":"10","key":"3031_CR32","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","volume":"11","author":"T Naftali","year":"2013","unstructured":"Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP, Sklerovsky Benjaminov F, Konikoff FM. Cannabis induces a clinical response in patients with Crohn\u2019s disease: a prospective placebo-controlled study. Clin Gastroenterol Hepatol. 2013;11(10):1276. https:\/\/doi.org\/10.1016\/j.cgh.2013.04.034.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3031_CR33","doi-asserted-by":"publisher","first-page":"908198","DOI":"10.3389\/fphar.2022.908198","volume":"13","author":"SM Anil","year":"2022","unstructured":"Anil SM, Peeri H, Koltai H. Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action. Front Pharmacol. 2022;13:908198. https:\/\/doi.org\/10.3389\/fphar.2022.908198.","journal-title":"Front Pharmacol"},{"key":"3031_CR34","doi-asserted-by":"publisher","first-page":"929222","DOI":"10.3389\/fimmu.2022.929222","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Lin C, Wu S, Zhang T, Wang Y, Jiang Y, et al. Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia. Front Immunol. 2022;13:929222. https:\/\/doi.org\/10.3389\/fimmu.2022.929222.","journal-title":"Front Immunol"},{"issue":"23","key":"3031_CR35","doi-asserted-by":"publisher","first-page":"16601","DOI":"10.3390\/ijms242316601","volume":"24","author":"MC Barbalace","year":"2023","unstructured":"Barbalace MC, Freschi M, Rinaldi I, Mazzara E, Maraldi T, Malaguti M, et al. Identification of Anti-Neuroinflammatory Bioactive Compounds in Essential Oils and Aqueous Distillation Residues Obtained from Commercial Varieties of Cannabis sativa L. IJMS. 2023;24(23):16601. https:\/\/doi.org\/10.3390\/ijms242316601.","journal-title":"IJMS"},{"issue":"15","key":"3031_CR36","doi-asserted-by":"publisher","first-page":"16517","DOI":"10.1021\/acsomega.9b02168","volume":"4","author":"S Wang","year":"2019","unstructured":"Wang S, Luo Q, Zhou Y, Fan P. CLG from Hemp Seed Inhibits LPS-Stimulated Neuroinflammation in BV2 Microglia by Regulating NF-\u03baB and Nrf-2 Pathways. ACS Omega. 2019;4(15):16517\u201323. https:\/\/doi.org\/10.1021\/acsomega.9b02168.","journal-title":"ACS Omega"},{"key":"3031_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbi.2023.05.008","volume":"111","author":"X Wang","year":"2023","unstructured":"Wang X, Lin C, Jin S, Wang Y, Peng Y, Wang X, Brain. Behav Immun. 2023;111:365\u201375. https:\/\/doi.org\/10.1016\/j.bbi.2023.05.008.","journal-title":"Behav Immun"},{"issue":"22","key":"3031_CR38","doi-asserted-by":"publisher","first-page":"16254","DOI":"10.3390\/ijms242216254","volume":"24","author":"S Fleisher-Berkovich","year":"2023","unstructured":"Fleisher-Berkovich S, Battaglia V, Baratta F, Brusa P, Ventura Y, Sharon N, et al. An Emerging Strategy for Neuroinflammation Treatment: Combined Cannabidiol and Angiotensin Receptor Blockers Treatments Effectively Inhibit Glial Nitric Oxide Release. IJMS. 2023;24(22):16254. https:\/\/doi.org\/10.3390\/ijms242216254.","journal-title":"IJMS"},{"key":"3031_CR39","doi-asserted-by":"publisher","first-page":"108582","DOI":"10.1016\/j.fsi.2023.108582","volume":"134","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Cui J, Liu Y, Gu L, Teng X, Tang Y. EGCG alleviated Mn exposure-caused carp kidney damage via trpm2-NLRP3-TNF-\u03b1-JNK pathway: Oxidative stress, inflammation, and tight junction dysfunction. Fish Shellfish Immunol. 2023;134:108582. https:\/\/doi.org\/10.1016\/j.fsi.2023.108582 . PubMed PMID: 36754155.","journal-title":"Fish Shellfish Immunol"},{"issue":"10","key":"3031_CR40","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1039\/c9fo01904a","volume":"10","author":"NM Rodriguez-Martin","year":"2019","unstructured":"Rodriguez-Martin NM, Toscano R, Villanueva A, Pedroche J, Millan F, Montserrat-de la Paz S, et al. Neuroprotective protein hydrolysates from hemp (Cannabis sativa L.) seeds. Food Funct. 2019;10(10):6732. https:\/\/doi.org\/10.1039\/c9fo01904a.","journal-title":"Food Funct"},{"key":"3031_CR41","doi-asserted-by":"publisher","unstructured":"Touri\u00f1o C, Zimmer A, Valverde O. THC Prevents MDMA Neurotoxicity in Mice. Albertson DN, editor. PLoS ONE. 2010;5(2):e9143. https:\/\/doi.org\/10.1371\/journal.pone.0009143.","DOI":"10.1371\/journal.pone.0009143"},{"issue":"4","key":"3031_CR42","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1021\/acs.jnatprod.3c00831","volume":"87","author":"E Gargiulo","year":"2024","unstructured":"Gargiulo E, Moriello AS, Benetti E, Pagni L, Arnoldi L, De Petrocellis L, et al. Phytochemical Characterization and TRPA1\/TRPM8 Modulation Profile of the Cannabigerol-Rich Cannabis sativa L. Chemotype IV. J Nat Prod (Washington DC). 2024;87(4):722\u201332. https:\/\/doi.org\/10.1021\/acs.jnatprod.3c00831.","journal-title":"J Nat Prod (Washington DC)"},{"issue":"6","key":"3031_CR43","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1124\/mol.111.071290","volume":"79","author":"AM Mart\u00edn-Moreno","year":"2011","unstructured":"Mart\u00edn-Moreno AM, Reigada D, Ram\u00edrez BG, Mechoulam R, Innamorato N, Cuadrado A, et al. Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer\u2019s Disease. Mol Pharmacol. 2011;79(6):964\u201373. https:\/\/doi.org\/10.1124\/mol.111.071290.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"3031_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12974-018-1288-0","volume":"15","author":"C Dello Russo","year":"2018","unstructured":"Dello Russo C, Cappoli N, Coletta I, Mezzogori D, Paciello F, Pozzoli G, et al. The human microglial HMC3 cell line: where do we stand? A systematic literature review. J Neuroinflammation. 2018;15(1):259. https:\/\/doi.org\/10.1186\/s12974-018-1288-0.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"3031_CR45","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.7150\/ijbs.4679","volume":"8","author":"M Erta","year":"2012","unstructured":"Erta M, Quintana A, Hidalgo J. Interleukin-6, a Major Cytokine in the Central Nervous System. Int J Biol Sci. 2012;8(9):1254\u201366. https:\/\/doi.org\/10.7150\/ijbs.4679.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3031_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12974-018-1308-0","volume":"15","author":"HY Nam","year":"2018","unstructured":"Nam HY, Nam JH, Yoon G, Lee JY, Nam Y, Kang HJ, et al. Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice. J Neuroinflammation. 2018;15(1):271. https:\/\/doi.org\/10.1186\/s12974-018-1308-0.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3031_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-6-9","volume":"6","author":"E Beurel","year":"2009","unstructured":"Beurel E, Jope RS. Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain. J Neuroinflammation. 2009;6(1):9. https:\/\/doi.org\/10.1186\/1742-2094-6-9.","journal-title":"J Neuroinflammation"},{"key":"3031_CR48","doi-asserted-by":"publisher","first-page":"1102465","DOI":"10.3389\/fphar.2023.1102465","volume":"14","author":"A Wagner","year":"2023","unstructured":"Wagner A, Pehar M, Yan Z, Kulka M. Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia. Front Pharmacol. 2023;14:1102465. https:\/\/doi.org\/10.3389\/fphar.2023.1102465.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3031_CR49","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41420-021-00471-7","volume":"7","author":"M Garcia-Contreras","year":"2021","unstructured":"Garcia-Contreras M, Thakor AS. Human adipose tissue-derived mesenchymal stem cells and their extracellular vesicles modulate lipopolysaccharide activated human microglia. Cell Death Discov. 2021;7(1):98. https:\/\/doi.org\/10.1038\/s41420-021-00471-7.","journal-title":"Cell Death Discov"},{"key":"3031_CR50","doi-asserted-by":"publisher","first-page":"116191","DOI":"10.1016\/j.bcp.2024.116191","volume":"228","author":"KCB Yabut","year":"2024","unstructured":"Yabut KCB, Winnie Wen Y, Simon KT, Isoherranen N. CYP2C9, CYP3A and CYP2C19 metabolize \u22069-tetrahydrocannabinol to multiple metabolites but metabolism is affected by human liver fatty acid binding protein (FABP1). Biochem Pharmacol. 2024;228:116191. https:\/\/doi.org\/10.1016\/j.bcp.2024.116191.","journal-title":"Biochem Pharmacol"},{"issue":"15","key":"3031_CR51","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.lfs.2006.12.032","volume":"80","author":"K Watanabe","year":"2007","unstructured":"Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I. Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci. 2007;80(15):1415\u20139. https:\/\/doi.org\/10.1016\/j.lfs.2006.12.032.","journal-title":"Life Sci"},{"issue":"4","key":"3031_CR52","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s11302-006-9023-1","volume":"2","author":"S Visentin","year":"2006","unstructured":"Visentin S, Nuccio CD, Bellenchi GC. Different patterns of Ca2\u2009+\u2009signals are induced by low compared to high concentrations of P2Y agonists in microglia. Purinergic Signalling. 2006;2(4):605\u201317. https:\/\/doi.org\/10.1007\/s11302-006-9023-1.","journal-title":"Purinergic Signalling"},{"key":"3031_CR53","doi-asserted-by":"publisher","first-page":"619458","DOI":"10.3389\/fphar.2020.619458","volume":"11","author":"AL Giuliani","year":"2021","unstructured":"Giuliani AL, Sarti AC, Di Virgilio F. Ectonucleotidases in Acute and Chronic Inflammation. Front Pharmacol. 2021;11:619458. https:\/\/doi.org\/10.3389\/fphar.2020.619458.","journal-title":"Front Pharmacol"},{"issue":"17","key":"3031_CR54","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.3390\/ijms21175996","volume":"21","author":"P Illes","year":"2020","unstructured":"Illes P. P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases. IJMS. 2020;21(17):5996. https:\/\/doi.org\/10.3390\/ijms21175996.","journal-title":"IJMS"},{"key":"3031_CR55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuroscience.2018.12.021","volume":"405","author":"S Calovi","year":"2019","unstructured":"Calovi S, Mut-Arbona P, Sperl\u00e1gh B. Microglia and the Purinergic Signaling System. Neuroscience. 2019;405:137\u201347. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.12.021.","journal-title":"Neuroscience"},{"key":"3031_CR56","unstructured":"Stewart A. NIAID BioArt Source: Receptor Protein [Digital image (public domain)]. 2025. Available from: https:\/\/bioart.niaid.nih.gov\/bioart\/651. Cited 2025 Aug 13."},{"key":"3031_CR57","unstructured":"Kissinger R. NIAID BioArt Source: TCell Receptor [Digital image (public domain)]. 2024. Located at: NIH. Available from: https:\/\/bioart.niaid.nih.gov\/bioart\/510. Cited 2025 Aug 13."},{"key":"3031_CR58","doi-asserted-by":"publisher","unstructured":"Chilton J. ATP. Zenodo; 2020. Available from: https:\/\/zenodo.org\/record\/3926309https:\/\/doi.org\/10.5281\/ZENODO.3926309.Cited 2025 Dec 2.","DOI":"10.5281\/ZENODO.3926309"},{"key":"3031_CR59","doi-asserted-by":"publisher","unstructured":"Chilton J. Microglia resting. Zenodo; 2020. Available from: https:\/\/zenodo.org\/record\/3926033https:\/\/doi.org\/10.5281\/ZENODO.3926033. Cited 2025 Dec 2.","DOI":"10.5281\/ZENODO.3926033"},{"key":"3031_CR60","unstructured":"Servier Medical Art. Empty cell. Available from: https:\/\/smart.servier.com\/smart_image\/cell-red-grey\/. Cited 2025 Dec 19."},{"issue":"10","key":"3031_CR61","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.3390\/ijms23105367","volume":"23","author":"S Yang","year":"2022","unstructured":"Yang S, Du Y, Zhao X, Tang Q, Su W, Hu Y, et al. Cannabidiol Enhances Microglial Beta-Amyloid Peptide Phagocytosis and Clearance via Vanilloid Family Type 2 Channel Activation. IJMS. 2022;23(10):5367. https:\/\/doi.org\/10.3390\/ijms23105367.","journal-title":"IJMS"},{"issue":"9","key":"3031_CR62","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1111\/bph.12615","volume":"171","author":"S Hassan","year":"2014","unstructured":"Hassan S, Eldeeb K, Millns PJ, Bennett AJ, Alexander SPH, Kendall DA. Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation. Br J Pharmacol. 2014;171(9):2426\u201339. https:\/\/doi.org\/10.1111\/bph.12615.","journal-title":"Br J Pharmacol"},{"issue":"24","key":"3031_CR63","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1111\/bph.15661","volume":"178","author":"LL Anderson","year":"2021","unstructured":"Anderson LL, Heblinski M, Absalom NL, Hawkins NA, Bowen MT, Benson MJ, et al. Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy. Br J Pharmacol. 2021;178(24):4826\u201341. https:\/\/doi.org\/10.1111\/bph.15661.","journal-title":"Br J Pharmacol"},{"issue":"Journal Article","key":"3031_CR64","doi-asserted-by":"publisher","first-page":"1048259","DOI":"10.3389\/fphar.2022.1048259","volume":"13","author":"M Udoh","year":"2022","unstructured":"Udoh M, Bladen C, Heblinski M, Luo JL, Janve VS, Anderson LL, et al. The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels. Front Pharmacol. 2022;13(Journal Article):1048259. https:\/\/doi.org\/10.3389\/fphar.2022.1048259.","journal-title":"Front Pharmacol"},{"issue":"17","key":"3031_CR65","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.3390\/molecules26175352","volume":"26","author":"A Straiker","year":"2021","unstructured":"Straiker A, Wilson S, Corey W, Dvorakova M, Bosquez T, Tracey J, et al. An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models. Molecules. 2021;26(17):5352. https:\/\/doi.org\/10.3390\/molecules26175352.","journal-title":"Molecules"},{"issue":"1","key":"3031_CR66","doi-asserted-by":"publisher","first-page":"zqad069","DOI":"10.1093\/function\/zqad069","volume":"5","author":"S Suzuki","year":"2023","unstructured":"Suzuki S, Wakano C, Monteilh-Zoller MK, Cullen AJ, Fleig A, Penner R. Cannabigerolic Acid (CBGA) Inhibits the TRPM7 Ion Channel Through its Kinase Domain. Function. 2023;5(1):zqad069. https:\/\/doi.org\/10.1093\/function\/zqad069.","journal-title":"Function"},{"key":"3031_CR67","doi-asserted-by":"publisher","first-page":"125766","DOI":"10.1016\/j.ijpharm.2025.125766","volume":"679","author":"MM El-Hammadi","year":"2025","unstructured":"El-Hammadi MM, Small-Howard AL, Fern\u00e1ndez-Ar\u00e9valo M, Turner H, Mart\u00edn-Banderas L. Effects of combined CBGA and cannabis-derived terpene nanoformulations on TRPV1 activation: Implications for enhanced pain management. Int J Pharm. 2025;679:125766. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125766.","journal-title":"Int J Pharm"},{"key":"3031_CR68","unstructured":"Penner R, NEUPANE RP. Cannabinoid compositions . WO2021188983A1. 2021. Available from: https:\/\/patents.google.com\/patent\/WO2021188983A1\/en?oq=WO2021188983A1 . Cited 2025 Dec 2."},{"key":"3031_CR69","unstructured":"SWISA R, IOSUB-AMIR A, SHAHARABANI R, Mechoulam R, Kogan NM. Cannabigerolic acid (cbga) derivatives and uses thereof . WO2021245672A1. 2021. Available from: https:\/\/patents.google.com\/patent\/WO2021245672A1\/en?oq=WO2021245672. Cited 2025 Dec 2."},{"key":"3031_CR70","unstructured":"MANALO-MORGAN A. Cannabinoid acid formulations, delivery systems, and methods of use . WO2023150192A1. 2023. Available from: https:\/\/patents.google.com\/patent\/WO2023150192A1\/en?oq=WO2023150192.Cited 2025 Dec 2."},{"key":"3031_CR71","unstructured":"Hsu E, Kadhim S, Somvanshi R, Kumar U. Compositions and methods for treating neuronal disorders with cannabinoids . WO2022082313A1, 2022 [cited 2025 Dec 2]. Available from: https:\/\/patents.google.com\/patent\/WO2022082313A1\/en?oq=WO2022082313A1"},{"key":"3031_CR72","unstructured":"WILLINSKY M. Novel anti-inflammatory, analgesic, anti-depressant cannabinoid and methods related to manufacture of same . WO2019210401A1. 2019. Available from: https:\/\/patents.google.com\/patent\/WO2019210401A1\/en?oq=WO2019210401. Cited 2025 Dec 2."},{"key":"3031_CR73","unstructured":"Walton R, Tucker M, Allen NASHD, WONFOR N, SHAH R. I. A cannabinoid mixture . WO2022167822A2. 2022. Available from: https:\/\/patents.google.com\/patent\/WO2022167822A2\/en?oq=WO2022167822. Cited 2025 Dec 2."},{"key":"3031_CR74","unstructured":"Altman E, Fuller M, ALSAIF G, Smith S, MAYNARD K. FARONE A. Cannabinoid compositions and methods of using . WO2020223510A1. 2020. . Available from: https:\/\/patents.google.com\/patent\/WO2020223510A1\/en?oq=WO2020223510. Cited 2025 Dec 2."},{"key":"3031_CR75","unstructured":"Ballan E, HOCHMAN I, YARIV G. BARAD E. Composition and method for treating cancer with cannabinoids . WO2021209990A1. 2021. Available from: https:\/\/patents.google.com\/patent\/WO2021209990A1\/en?oq=WO2021209990A1. Cited 2025 Dec 2."},{"key":"3031_CR76","unstructured":"JAVID F, DUNCAN M, Stott C. The use of phytocannabinoids in the treatment of ovarian carcinoma . WO2014202990A1. 2014. Available from: https:\/\/patents.google.com\/patent\/WO2014202990A1\/en?oq=WO2014202990A1 .Cited 2025 Dec 2."},{"key":"3031_CR77","unstructured":"Stott C, DUNCAN M, Hill T. Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer . WO2015198071A1. 2015. Available from: https:\/\/patents.google.com\/patent\/WO2015198071A1\/en?oq=WO2015198071A1 .Cited 2025 Dec 2."},{"key":"3031_CR78","unstructured":"Elzufon M, Hoffberg H. Cannabigerolic acid (cbga) and cannabigerol (cbg) derived products and methods of use . WO2024108201A2. 2024. Available from: https:\/\/patents.google.com\/patent\/WO2024108201A2\/en?oq=WO2024108201. Cited 2025 Dec 2."},{"key":"3031_CR79","unstructured":"Hari V. Method and composition for preventing and treating viral respiratory infections . US20230330037A1. 2023. Available from: https:\/\/patents.google.com\/patent\/US20230330037A1\/en?oq=US20230330037A1. Cited 2025 Dec 2]"},{"key":"3031_CR80","unstructured":"BRYANT CW WATTAA. Use of cannabinoid compounds in the treatment of skin damage and skin disorders . WO2023130139A2. 2023. Available from: https:\/\/patents.google.com\/patent\/WO2023130139A2\/en?oq=WO2023130139. Cited 2025 Dec 2."},{"key":"3031_CR81","unstructured":"BRYANT CW WATTAA. Oral care product with cannabinoid compounds . WO2022204731A1. 2022. Available from: https:\/\/patents.google.com\/patent\/WO2022204731A1\/en?oq=WO2022204731A1. Cited 2025 Dec 2."},{"issue":"23","key":"3031_CR82","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1111\/bph.14019","volume":"174","author":"X Nadal","year":"2017","unstructured":"Nadal X, Del R\u00edo C, Casano S, Palomares B, Ferreiro-Vera C, Navarrete C, et al. Tetrahydrocannabinolic acid is a potent PPAR\u03b3 agonist with neuroprotective activity. Br J Pharmacol. 2017;174(23):4263\u201376. https:\/\/doi.org\/10.1111\/bph.14019.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"3031_CR83","doi-asserted-by":"publisher","first-page":"114894","DOI":"10.1016\/j.celrep.2024.114894","volume":"43","author":"A Boutou","year":"2024","unstructured":"Boutou A, Roufagalas I, Politopoulou K, Tastsoglou S, Abouzeid M, Skoufos G, et al. Microglia regulate cortical remyelination via TNFR1-dependent phenotypic polarization. Cell Rep. 2024;43(11):114894. https:\/\/doi.org\/10.1016\/j.celrep.2024.114894.","journal-title":"Cell Rep"},{"issue":"1","key":"3031_CR84","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12974-014-0215-2","volume":"11","author":"LW Wang","year":"2014","unstructured":"Wang LW, Chang YC, Chen SJ, Tseng CH, Tu YF, Liao NS, et al. TNFR1-JNK signaling is the shared pathway of neuroinflammation and neurovascular damage after LPS-sensitized hypoxic-ischemic injury in the immature brain. J Neuroinflammation. 2014;11(1):215. https:\/\/doi.org\/10.1186\/s12974-014-0215-2.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3031_CR85","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12974-016-0486-x","volume":"13","author":"S Swaroop","year":"2016","unstructured":"Swaroop S, Sengupta N, Suryawanshi AR, Adlakha YK, Basu A. HSP60 plays a regulatory role in IL-1\u03b2-induced microglial inflammation via TLR4-p38 MAPK axis. J Neuroinflammation. 2016;13(1):27. https:\/\/doi.org\/10.1186\/s12974-016-0486-x.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"3031_CR86","doi-asserted-by":"publisher","first-page":"e0183114","DOI":"10.1371\/journal.pone.0183114","volume":"12","author":"P Jiang","year":"2017","unstructured":"Jiang P, Xing F, Guo B, Yang J, Li Z, Wei W et al. V <>Lionetti editor 2017 Nucleotide transmitters ATP and ADP mediate intercellular calcium wave communication via P2Y12\/13 receptors among BV-2 microglia. PLoS ONE 12 8 e0183114 https:\/\/doi.org\/10.1371\/journal.pone.0183114.","journal-title":"PLoS ONE"},{"issue":"12","key":"3031_CR87","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1016\/j.bbamcr.2013.06.022","volume":"1833","author":"M Ikeda","year":"2013","unstructured":"Ikeda M, Tsuno S, Sugiyama T, Hashimoto A, Yamoto K, Takeuchi K, et al. Ca 2\u2009+\u2009spiking activity caused by the activation of store-operated Ca 2\u2009+\u2009channels mediates TNF-\u03b1 release from microglial cells under chronic purinergic stimulation. Biochimica et Biophysica Acta (BBA) -. Mol Cell Res. 2013;1833(12):2573\u201385. https:\/\/doi.org\/10.1016\/j.bbamcr.2013.06.022.","journal-title":"Mol Cell Res"},{"issue":"1","key":"3031_CR88","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12974-021-02096-0","volume":"18","author":"NP Palomba","year":"2021","unstructured":"Palomba NP, Martinello K, Cocozza G, Casciato S, Mascia A, Di Gennaro G, et al. ATP-evoked intracellular Ca2\u2009+\u2009transients shape the ionic permeability of human microglia from epileptic temporal cortex. J Neuroinflammation. 2021;18(1):44. https:\/\/doi.org\/10.1186\/s12974-021-02096-0.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3031_CR89","first-page":"14","volume":"3","author":"S Gorini","year":"2013","unstructured":"Gorini S, Gatta L, Pontecorvo L, Vitiello L, la Sala A. Regulation of innate immunity by extracellular nucleotides. Am J Blood Res. 2013;3(1):14\u201328. PubMed PMID: 23358447; PubMed Central PMCID: PMC3555188.","journal-title":"Am J Blood Res"},{"key":"3031_CR90","doi-asserted-by":"publisher","first-page":"109333","DOI":"10.1016\/j.neuropharm.2022.109333","volume":"224","author":"F Di Virgilio","year":"2023","unstructured":"Di Virgilio F, Vultaggio-Poma V, Falzoni S, Giuliani AL, Extracellular ATP. A powerful inflammatory mediator in the central nervous system. Neuropharmacology. 2023;224:109333. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109333.","journal-title":"Neuropharmacology"},{"key":"3031_CR91","unstructured":"Haynes SE. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. UCSF; 2006. Available from: https:\/\/escholarship.org\/uc\/item\/02d349pn. Cited 2026 May 27."},{"issue":"10","key":"3031_CR92","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1016\/j.bbamem.2014.05.015","volume":"1838","author":"LA Alves","year":"2014","unstructured":"Alves LA, de Melo Reis RA, de Souza CAM, de Freitas MS, Teixeira PCN, Neto Moreira Ferreira D, et al. The P2X7 receptor: Shifting from a low- to a high-conductance channel \u2014 An enigmatic phenomenon? Biochimica et Biophysica Acta (BBA). - Biomembr. 2014;1838(10):2578\u201387. https:\/\/doi.org\/10.1016\/j.bbamem.2014.05.015.","journal-title":"- Biomembr"},{"issue":"3","key":"3031_CR93","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11302-021-09790-x","volume":"17","author":"LH Jiang","year":"2021","unstructured":"Jiang LH, Caseley EA, Muench SP, Roger S. Structural basis for the functional properties of the P2X7 receptor for extracellular ATP. Purinergic Signalling. 2021;17(3):331\u201344. https:\/\/doi.org\/10.1007\/s11302-021-09790-x.","journal-title":"Purinergic Signalling"},{"issue":"3","key":"3031_CR94","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","volume":"79","author":"S Latini","year":"2001","unstructured":"Latini S, Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem. 2001;79(3):463\u201384. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00607.x.","journal-title":"J Neurochem"},{"issue":"3","key":"3031_CR95","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","volume":"8","author":"H Zimmermann","year":"2012","unstructured":"Zimmermann H, Zebisch M, Str\u00e4ter N. Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal. 2012;8(3):437\u2013502. https:\/\/doi.org\/10.1007\/s11302-012-9309-4 . PubMed PMID: 22555564; PubMed Central PMCID: PMC3360096.","journal-title":"Purinergic Signal"},{"key":"3031_CR96","doi-asserted-by":"publisher","unstructured":"Shigetomi E, Sakai K, Koizumi S Extracellular ATP\/adenosine dynamics in the brain and its role in health and disease. Front Cell Dev Biol. 2024;11. . https:\/\/doi.org\/10.3389\/fcell.2023.1343653.","DOI":"10.3389\/fcell.2023.1343653"},{"issue":"3","key":"3031_CR97","doi-asserted-by":"publisher","first-page":"20120101","DOI":"10.1098\/rsfs","volume":"3","author":"S Falzoni","year":"2013","unstructured":"Falzoni S, Donvito G, Di Virgilio F. Detecting adenosine triphosphate in the pericellular space. Interface Focus. 2013;3(3):20120101. https:\/\/doi.org\/10.1098\/rsfs. 2012.0101 PubMed PMID: 23853707; PubMed Central PMCID: PMC3638417.","journal-title":"Interface Focus"},{"issue":"11","key":"3031_CR98","doi-asserted-by":"publisher","first-page":"e21265","DOI":"10.1016\/j.heliyon.2023.e21265","volume":"9","author":"T Puopolo","year":"2023","unstructured":"Puopolo T, Cai A, Liu C, Ma H, Seeram NP. Investigating cannabinoids as P2X purinoreceptor 4 ligands by using surface plasmon resonance and computational docking. Heliyon. 2023;9(11):e21265. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21265.","journal-title":"Heliyon"},{"issue":"1","key":"3031_CR99","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1476-5381.2010.00683.x","volume":"160","author":"J Sim","year":"2010","unstructured":"Sim J, North R. Amitriptyline does not block the action of ATP at human P2X4 receptor. Br J Pharmacol. 2010;160(1):88\u201392. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00683.x.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"3031_CR100","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/mol.114.096222","volume":"87","author":"AR Ase","year":"2015","unstructured":"Ase AR, Honson NS, Zaghdane H, Pfeifer TA, S\u00e9gu\u00e9la P. Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels. Mol Pharmacol. 2015;87(4):606. https:\/\/doi.org\/10.1124\/mol.114.096222.","journal-title":"Mol Pharmacol"},{"issue":"6","key":"3031_CR101","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11302-024-10018-x","volume":"20","author":"A Fortuny-Gomez","year":"2024","unstructured":"Fortuny-Gomez A, Fountain SJ. Pharmacological differences between human and mouse P2X4 receptor explored using old and new tools. Purinergic Signalling. 2024;20(6):659\u201367. https:\/\/doi.org\/10.1007\/s11302-024-10018-x.","journal-title":"Purinergic Signalling"},{"key":"3031_CR102","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.bbi.2020.04.051","volume":"88","author":"MP Boks","year":"2020","unstructured":"Boks MP, He Y, Schubart CD, Gastel WV, Elkrief L, Huguet G, et al. Cannabinoids and psychotic symptoms: A potential role for a genetic variant in the P2X purinoceptor 7 (P2RX7) gene. Brain Behav Immun. 2020;88:573\u201381. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.051.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"3031_CR103","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/glia.24489","volume":"72","author":"M Dos Santos Pereira","year":"2024","unstructured":"Dos Santos Pereira M, Maitan Santos B, Gimenez R, Guimar\u00e3es FS, Raisman-Vozari R, Del Bel E, et al. The two synthetic cannabinoid compounds 4\u2032\u2010 F\u2010CBD and HU \u2010910 efficiently restrain inflammatory responses of brain microglia and astrocytes. Glia. 2024;72(3):529\u201345. https:\/\/doi.org\/10.1002\/glia.24489.","journal-title":"Glia"},{"issue":"18","key":"3031_CR104","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.3390\/molecules28186487","volume":"28","author":"EG Gojani","year":"2023","unstructured":"Gojani EG, Wang B, Li DP, Kovalchuk O, Kovalchuk I. Anti-Inflammatory Effects of Minor Cannabinoids CBC, THCV, and CBN in Human Macrophages. Molecules. 2023;28(18):6487. https:\/\/doi.org\/10.3390\/molecules28186487.","journal-title":"Molecules"},{"issue":"3\u20134","key":"3031_CR105","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ceca.2005.06.014","volume":"38","author":"T Ohno-Shosaku","year":"2005","unstructured":"Ohno-Shosaku T, Hashimotodani Y, Maejima T, Kano M. Calcium signaling and synaptic modulation: regulation of endocannabinoid-mediated synaptic modulation by calcium. Cell Calcium. 2005;38(3\u20134):369\u201374. https:\/\/doi.org\/10.1016\/j.ceca.2005.06.014 . PubMed PMID: 16085309.","journal-title":"Cell Calcium"},{"issue":"6","key":"3031_CR106","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41580-024-00820-1","volume":"26","author":"B Cartes-Saavedra","year":"2025","unstructured":"Cartes-Saavedra B, Ghosh A, Hajn\u00f3czky G. The roles of mitochondria in global and local intracellular calcium signalling. Nat Rev Mol Cell Biol. 2025;26(6):456\u201375. https:\/\/doi.org\/10.1038\/s41580-024-00820-1.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"3031_CR107","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10863-021-09878-4","volume":"53","author":"OR Pereira","year":"2021","unstructured":"Pereira OR, Ramos VM, Cabral-Costa JV, Kowaltowski AJ. Changes in mitochondrial morphology modulate LPS-induced loss of calcium homeostasis in BV-2 microglial cells. J Bioenerg Biomembr. 2021;53(2):109\u201318. https:\/\/doi.org\/10.1007\/s10863-021-09878-4 . PubMed PMID: 33585958.","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"3031_CR108","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-021-02187-y","volume":"18","author":"J Cheng","year":"2021","unstructured":"Cheng J, Zhang R, Xu Z, Ke Y, Sun R, Yang H, et al. Early glycolytic reprogramming controls microglial inflammatory activation. J Neuroinflammation. 2021;18(1):129. https:\/\/doi.org\/10.1186\/s12974-021-02187-y.","journal-title":"J Neuroinflammation"},{"key":"3031_CR109","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-3-031","volume":"37","author":"O Garaschuk","year":"2024","unstructured":"Garaschuk O, Verkhratsky A. Calcium Signalling in Microglia. Adv Neurobiol. 2024;37:123\u201333. https:\/\/doi.org\/10.1007\/978-3-031-. 55529-9_7 PubMed PMID: 39207689.","journal-title":"Adv Neurobiol"},{"key":"3031_CR110","unstructured":"Tam YK, BJORNDAHL T, Tseng CY. Compositions of a cannabinoid and a kinase inhibitor for the treatment of cancer . WO2024164085A1. 2024. Available from: https:\/\/patents.google.com\/patent\/WO2024164085A1\/en?oq=WO2024164085. Cited 2025 Dec 2."},{"key":"3031_CR111","unstructured":"CAPANO AM, Tanwar PS, Nance A. Methods of treating ovarian cancer with hemp extract . WO2023076928A1. 2023. Available from: https:\/\/patents.google.com\/patent\/WO2023076928A1\/en?oq=WO2023076928. Cited 2025 Dec 2."},{"key":"3031_CR112","unstructured":"YARIV GA, Ballan E, HOCHMAN I. BARAD E. Compositions comprising cannabinoids and methods of use thereof in the treatment of cancer . WO2023062634A1. 2023. Available from: https:\/\/patents.google.com\/patent\/WO2023062634A1\/en?oq=WO2023062634. Cited 2025 Dec 2."},{"key":"3031_CR113","unstructured":"Tsagareli M, Kvachadze I, Simone D, ANTINOCICEPTIVE TOLERANCE TO. CANNABINOIDS IN ADULT MALE MICE: A PILOT STUDY. Georgian medical news. 2021;(320):148."},{"key":"3031_CR114","unstructured":"KORNBLAU S, LEVINTON G, HERSHKOVITS S, RAPOPORT A, BARAK L, Goldberg E et al. Cannabis compositions enriched with cbca\/cbc for consistent pain relief . EP4595958A1. 2025. Available from: https:\/\/patents.google.com\/patent\/EP4595958A1\/de?oq=EP4595958A1. Cited 2025 Dec 2."},{"issue":"2","key":"3031_CR115","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1021\/acschemneuro.0c00677","volume":"12","author":"LL Anderson","year":"2021","unstructured":"Anderson LL, Ametovski A, Lin Luo J, Everett-Morgan D, McGregor IS, Banister SD, et al. Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome. ACS Chem Neurosci. 2021;12(2):330. https:\/\/doi.org\/10.1021\/acschemneuro.0c00677.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"3031_CR116","doi-asserted-by":"publisher","first-page":"15621","DOI":"10.1038\/s41598-025-99867-z","volume":"15","author":"Z Woolf","year":"2025","unstructured":"Woolf Z, Stevenson TJ, Lee K, Highet B, Macapagal Foliaki J, Ratiu R, et al. In vitro models of microglia: a comparative study. Sci Rep. 2025;15(1):15621. https:\/\/doi.org\/10.1038\/s41598-025-99867-z.","journal-title":"Sci Rep"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03031-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:02:36Z","timestamp":1790946156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-03031-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3031"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-03031-7","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental work involving phytocannabinoids classified as Schedule I controlled substances was conducted in full compliance with U.S. federal regulations and authorized under Drug Enforcement Administration (DEA) registration number RP0510873. ChatGPT (OpenAI) was employed for editorial and stylistic assistance only. No AI tools were used to generate, analyze, or interpret data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"525"}}